Making Sense of Hierarchical Composite End Points in Randomized Clinical Trials-A Primer for Infectious Diseases Clinicians and Researchers

理解随机临床试验中的分层复合终点——传染病临床医生和研究人员入门指南

阅读:3

Abstract

Hierarchical composite end points (HCEs), combining features of simple composite end points and conventional ordinal end points, are increasingly being used in infectious diseases (ID) research. However, many clinicians may be unfamiliar with these novel end points, including the variety of different target parameters that may be of interest and the methods that can be used to estimate them. In this review, we provide a conceptual overview of HCEs by defining them and providing examples from the ID literature. We explain different methods for analyzing HCEs, including (1) the Wilcoxon rank sum approach (often used in studies with a desirability of outcome ranking [DOOR] end point), (2) generalized pairwise comparisons (used to estimate a win ratio or win odds), (3) proportional odds model (and the relevance of the proportional odds assumption), and, (4) the probabilistic index model. This review will help ID clinicians and healthcare providers interpret current and future research using such end points.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。